Intratumor genetic or epigenetic heterogeneity has been found in many cancers as evidenced by deep sequencing selectively applied to different parts of the same tumor 1, 2 . Consequently, cancer cells display remarkable phenotypic variability, including ability to induce angiogenesis, seed metastases, and survive therapy [3] [4] [5] . Advanced solid tumors often contain vascular compartments with distinct pharmacokinetics, comprising hypoxic regions and spatially intermingled irregular vasculature that is leaky and inefficient [6] [7] [8] . The complexity of heterogeneity has clinical implications. A more heterogeneous tumor is more likely to fail therapy due to increased drug-resistant variants 3, 5 , and characteristics of the dominant cell type will not necessarily predict the behaviors of interest rooted in specific cells 4 .
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) provides a noninvasive in vivo method to evaluate tumor vasculature architectures based on contrast accumulation and washout 7, 9 . While DCE-MRI can potentially depict the intratumor heterogeneity of vascular permeability 10 , the quantitative application of DCE-MRI has been hindered by its inability to accurately resolve vascular compartments with distinct pharmacokinetics due to limited imaging resolution 7, 11 . This indistinction among the contributions of different compartments to the mixed tracer signals can confound compartment modeling and deep phenotyping for association studies 4, 12, 13 . The goal of the present work was to discern vascular heterogeneity and its changes in tumors using DCE-MRI and novel mathematical models, for personalized cancer diagnosis and treatment.
We developed a computational method (multi-tissue compartment modeling -MTCM)
for deconvolving intratumor vascular heterogeneity and identifying pharmacokinetics changes in many biological contexts 5, 14, 15 . MTCM works by applying a convex analysis of mixtures that enables geometrically-principled delineation of distinct vascular structures from DCE-MRI data ( Fig. 1a-c) . A formal mathematical description of the method and its detailed implementation is available in Methods.
Results

Overview of MTCM.
Tumors to be analyzed by MTCM contain unknown numbers of distinct vascular compartments. The pixel-wise tracer concentration in a particular vascular compartment is modeled as being proportional to the local volume transfer constant of the vascular compartment (Method). Because there are often significant numbers of partial-volume pixels, MTCM instead estimates pharmacokinetic parameters (flux rate constants) via the timecourses of pure-volume pixels (pixels whose signal is highly enriched in a particular vascular compartment). Convex analysis of mixtures identifies those pure-volume pixels present at the vertices of the clustered pixel time series scatter simplex, without any knowledge of compartment distribution (Method) . When the number of underlying vascular compartments is detected using the minimum description length (MDL) criterion, MTCM provides a completely unsupervised approach to characterize intratumor heterogeneity (Methods and Appendix
1.Supplementary Discussion).
Modeling the pharmacokinetics of each vascular compartment using pure-volume pixel time-courses allowed us to estimate individual compartment flux rate constants ( Fig. 1d-e) .
Non-negative least-square estimation yielded pixel-wise local volume transfer constants (Methods and Fig. 1f ). Using synthetic and mouse DCE-MRI experiments, we showed that MTCM can be used to estimate pharmacokinetic parameters in several vascular compartments simultaneously and to quantitatively reconstruct tissue-specific local volume transfer constants Furthermore, MTCM enabled quantitation of differences in tissue-specific vascular permeability across time (for example, therapeutic responses in longitudinal studies; Methods).
Thus, the change in values of flux rate constants in a given vascular compartment could be determined, despite an expected difference in that vascular compartment's relative abundance.
We also analyzed the same realistic synthetic dataset using a "traditional" way of . We should clarify that MTCM consists of two major analytic parts: convex analysis of mixtures (CAM) and compartment modeling (CM), where the CAM is a critical step that automatically identifies the pure tissue pixels and their time activity curves, followed by the CM that estimates the pharmacokinetics parameters without being contaminated by the partial-volume effect. In contrast, since PCA does not enforce the nonnegative constraint for tracer concentration estimation, a subsequent compartment modeling cannot be performed to estimate pharmacokinetic parameters.
Intratumor vascular heterogeneity in breast cancer revealed by MTCM. In keeping with our goal to use MTCM to better uncover vascular heterogeneity in human tumors, we applied MTCM to DCE-MRI sequence data obtained from a case of advanced breast cancer (Fig. 1a) .
In this breast tumor 7 , vascular heterogeneity is characterized by active angiogenesis in the peripheral "rim" and concurrent inner-core hypoxia. Upon preliminary analysis using MDL, we found that a two-tissue compartment model of the fast and slow tracer clearance rates was sufficient to account for the variable permeability at the majority of pixels (Methods). Thus, we used pure-volume pixels associated with these two vascular pools to estimate tissue-specific flux rate constants and to reconstruct local volume transfer constant maps (Methods). MTCM reveals two vascular compartments with distinct flux rate constants (Fig. 1e) . Accordingly, we detected distinct spatial patterns of specific local volume transfer constant in the two vascular compartments ( Fig. 1f) with a significant fraction of partial volume pixels.
Intratumor vascular heterogeneity identified by MTCM is consistent with the knowledge obtained from ex vivo microscopic and molecular studies 7, 13 . Defective endothelial barrier function is one of the better documented abnormalities of tumor vessels, resulting in functional heterogeneity in vascular permeability to macromolecules 7, 11 . As a tumor rapidly outgrows its blood supply, it requires neovessel maturation, often leaving an inner core of the tumor with regions where blood flow and oxygen concentration are significantly lower than in normal tissues 6 . MTCM reconstructed local volume transfer constant maps correlate well with the differential gene expression known to regulate angiogenesis 7, 13 .
Changes in intratumor vascular heterogeneity in longitudinal studies. We also detected changes in pharmacokinetic patterns among longitudinal DCE-MRI data from breast cancer acquired before, during, and after treatment (Fig. 2a) , quantified as different flux rate constants over time (Methods and Supplementary Table 3 ). For example, the two vascular compartment time-activity curves revealed by MTCM in the baseline data are highly distinct (Fig. 2b) . We detected significantly higher permeability in a fast-flow pool and slightly lower permeability in a slow-flow pool when compared with the normal state. In contrast, the interim response ( Fig. 2c) exhibits vascular compartment time-activity curves that are distinct but much closer to each other, whereas the closing response (Fig. 2d) shows a significant decrease in permeability of the fast-flow pool. We also detected different local volume transfer constant maps ( Fig. 2b-d) and changes in the fractions of partial-volume pixels (Supplementary Table   4 ).
Comparative studies using standard compartment modeling. We compared tissue-specific pharmacokinetics detected with MTCM to the results of a standard compartment analysis of (total) vascular pool within the region of interest. Total time-activity curves were indistinct across time (Supplementary Fig. 2 ) owing to therapeutic effects in some parts of the tumor but not in others and large fractions of partial-volume pixels. In this longitudinal study, we deconvolved total time-activity curves into two phased therapeutic effects using MTCM: a transient "normalization" of abnormal yet surviving tumor vasculature together with the significant and consistent drop in the relative volume transfer constants 6, 16 . In contrast, standard analysis may not return informative results when both the flux rate constant and volume transfer constant change heterogeneously in response to therapy. These examples illustrate the ability of MTCM to discover intratumor vascular heterogeneity and to detect changes in each vascular compartment over time. Finally, we tested the applicability of MTCM to dynamic fluorescence imaging data acquired on a mouse after bolus injection of indocyanine green dye by deconvolving biodistribution dynamics of the major organs 17 ( Supplementary   Fig. 3 ). The dissected tissue compartments constitute anatomical structures of the mouse that agree well with a digital anatomical mouse atlas.
Discussion
Several previous studies have discussed the problem of intratumor vascular heterogeneity in compartment modelling 7, 11, 16, 18 , a major outstanding issue for the characterization of complex phenotypes and therapeutic responses. Some methods have addressed the estimation of multi-compartment pharmacokinetics in the presence of varying partial-volume effects, relying on known regions of pure-volume pixels and number of compartments 10, 13, 16, 17 . The significant advantage of our strategy is its ability to detect and quantify intratumor vascular heterogeneity without any type of external information. The benefits of such a method include its wide applicability, sensitive detection of heterogeneity dynamics, and reliance on longitudinal data from one single subject (Appendix 1.
Supplementary Discussion).
We have identified differential and heterogeneous changes in tissue-specific vascular pharmacokinetics in tumors during treatment that were undetected using standard analysis, including tumor islands of persistent enhancement that have escaped the effects of therapy 18 .
These results are particularly intriguing when considered together with recent imaging studies describing foci of resistant and more aggressive clones within a tumor 5, 13 . While it is not yet possible to assign causality, these in vivo results allowed us to propose new hypotheses regarding the complex relationships between intratumor heterogeneity, clonal repopulation, cancer stem-cell, and therapeutic efficacy 1, 3, 5, 10, 19 .
In metastatic disease, recent studies have revealed the emergence of treatment-resistant subclones that were present at a minor frequency in the primary tumour 20 . Thus, modeling cancer diagnosis and treatment in the future should involve characterization of subpopulations within the primary tumour, monitoring of clonal dynamics during treatment and eradication of treatment-emergent clones 21 . To prospectively assess intratumor heterogeneity, profiling of multiregional tumour samples would be required. However, it is impractical and potentially risky to take multiple 'random' biopsies in every patient, owing to both sampling bias and the inability to resolve intermingled heterogeneity 22 . MTCM would not only make longitudinal in vivo surveillance possible but also enable imaging-informed selective biopsies. So far we have tested MTCM method on DCE-MRI data, dynamic contrast-enhanced optical imaging data, and dynamic PET imaging data, acquired from both human tissue/organ and whole-body mouse model (e.g., Supplementary Fig. 4 ). Theoretically, the MTCM method can produce confident estimation on any 'dynamic contrast-enhanced' imaging data with sufficient quality (e.g., spatial and temporal resolution) [23] [24] [25] . However, we should emphasize that there are a few fundamental assumptions behind the MTCM methodology, as specified in the newly proved theorems (e.g., linear convex combination, existence of pure-tissue pixels).
As in most medical imaging analysis, object motion constitutes a major source of error and can significantly confound the modeling results. Currently, MTCM is limited to 'parallel' compartment models, while the CAM part of the MTCM algorithm is applicable to resolving partial-volume contamination problem independent of the compartment models being used for subsequent parameter estimation. 
Methods
Multi
where measured ( , ) 
Parallelism between multi-tissue compartment modeling and the theory of convex sets.
Apply a sum-based normalization to pixel time-course measured ( , ) l C i t and using vector-matrix notation, we can re-express (2) as 
MTCM exploits the strong parallelism between the multi-compartment model (3) and the theory of convex set. The fundamental principle is that latent compartments are pure vasculatures in a tumor whose pharmacokinetics { } j C reside at the extremities of the scatter simplex occupied by the pixel time-courses, and accordingly, the interior of the simplex is occupied by the partial-volume pixels (linear non-negative mixtures of compartments) (Fig.   1b) . Estimates of compartment pharmacokinetics may then be derived from the vertices of the multifaceted simplex that most tightly encloses the pixel time-courses and has the same number of compartments as vertices ( Fig. 1d ) 29 .MTCM algorithm is supported theoretically by a wellgrounded mathematical frameworkas summarised below (see formal proofs in Appendix 2.
Supplementary Method). when there is at least one pixel whose signal is highly and exclusively enriched in a particular vascular compartment (Fig. 1b) . This means that, in principle, under a noise-free scenario, we can directly estimate { } j C by locating the vertices of { } measured   (Fig. 1d ).
Theorem 1 (Convexity of pixel time-course).Suppose
Theorem 2 (Optimum source dominance). Suppose that the local volume transfer constants
Data preprocessing (Fig. 1a) . First, the tumor area is extracted by masking out the non-tumor tissues surrounding the tumor site 30 . Second, the first few image frames, such as the four initial images of DCE-MRI sequences in our experiments, are removed because they correspond to the time prior to sufficient onsite tracer uptake. Third, pixels whose temporal average signal intensity is lower than 5% of the maximum value, or whose temporal dynamic variation is lower than 5% of the maximum value, are eliminated, because these non-informative pixels could have a negative impact on subsequent analyses. Fourth, the pixel time series is normalized over time using a sum-based normalization scheme, focusing the analysis on the "shape" of pharmacokinetics rather than on absolute tracer concentration.
It is true that accurate extraction of tumor region is critical to any image-based analysis that is focused on tumor characterization, where non-tumor tissue would constitute a confounding factor. Theoretically, MTCM method can handle well such situation since it is a completely unsupervised approach, relying on the MDL-based model selection. Specifically, since MTCM is specifically designed to work on multiple tissue compartment modeling, when a significant portion of the surrounding healthy tissue is included in the processed 'tumor' area, the healthy tissue will be considered as an additional/individual compartment in Eq. (1) and ). In the case of heavy noise and fuzzy boundary, a consensus approach may be adopted that surveys the results of multiple methods. (Fig. 1b) . To reduce the impact of noise/outlier data points, improve the efficiency of subsequent convex analysis of mixtures, and permit an automated determination of the number of underlying vascular compartments using the minimum description length (MDL) criterion, we aggregated pixel time-courses into representative clusters using a combined affinity propagation and expectation-maximization clustering 31 (Appendix 2. Supplementary Method).As an initialization-free and near-global-optimum clustering method, affinity propagation clustering (APC) simultaneously considers all data points as potential exemplars and recursively exchange real-valued messages between data points until a high-quality set of exemplars and corresponding clusters gradually emerges. Let the "similarity" ( ) , s i m indicate how well the mth data point is suited to be the exemplar for ith data point; the "responsibility" ( ) , r i m reflects the accumulated evidence for how wellsuited the mth data point is to serve as the exemplar for the ith data point; the "availability" ( ) , a i m reflects the accumulated evidence for how appropriate the ith data point chooses mth data point as its exemplar. Then, supposing that there are N data points (e.g., pixels) in total, the responsibilities ( )
Clustering of pixel time-course
where the availabilities ( ) , a i m are initialized to zero and the competitive update rule (5) is purely data-driven. Whereas the responsibility update (5) allows all candidate exemplars to compete for ownership of a data point, the availability update rule
collects evidence from data points to support a good exemplar, where the "self-availability" is (Fig. 1d) . To identify the vertices of convex set { } Supplementary Method) . We used the margin-of-error
Convex analysis of mixtures
to quantify the distance between m C and convex set { } M J J C ∈   , where we have
. We then selected the most probable J vertices when the corresponding sum of the margin between the convex hull and the remaining "exterior" cluster centers reaches its minimum:
Model selection procedure. One important discovery step concerning MTCM is to detect the number J of the underlying tissue compartments. We used MDL, a widely-adopted and consistent information theoretic criterion, to guide model selection (Appendix 2.
Supplementary Method).
We performed CAM on several competing candidates, and selected the optimal model that assigns high probabilities to the observed data while at the same time whose parameters are not too complex to encode 32 . Specifically, a model is selected with J tissue compartments by minimizing the total description code length defined by ( ) arg min subject to 0 and 0 
which readily reveals the intratumor vascular heterogeneity.
Synthetic DCE-MRI datasets. We first validated MTCM-generated estimates of tissuespecific vascular pharmacokinetics parameters using a set of realistic synthetic DCE-MRI data with known parameter values. We set J=3, indexing two tissue compartments and one plasma input. We generated a large number of synthetic DCE-MRI time series by multiplying the (Fig. 3) .
Characterization of differential vascular pharmacokinetics in advanced breast cancer case. In the second application, we analyzed the real DCE-MRI data of an advanced breast tumor using both MTCM and the classic method. The T1-weighted gadolinium-enhanced (Gd-DTPA)DCE-MRI data set was acquired by three-dimensional scans performed every 30 seconds for a total of 11 minutes after the injection, on a 1.5 Tesla magnet using threedimensional spoiled gradient-echo sequences (TR < 7 msec, TE < 1.5 msec, flip angle = 30°, matrix = 192 × 256, 0.5 averages). Typically, 12-15 slices are obtained and 15-18 time frames are acquired for each case. We visually examined the convexity of projected pixel time-course via the top two convexity-preserved projections where the margin between the "exterior" data points and the convex hull is minimized. We observed that two-tissue compartments (a threevertex convex set) were sufficient to describe the observed pixel time-course scatter simplex.
While additional compartments can be used to account for outlier vertices, these compartments become difficult to interpret. We analyzed the dataset by setting Data 3) . Three sets of DCE-MRI data were acquired during standard treatment, each three months apart, serving as the potential endpoints in assessing the response to therapy. To detect various yet potentially hidden changes accounting for intratumor heterogeneity, we applied the same MTCM and MDL (as well as the classic method) to the three data sets separately.
Open source multiplatform standalone MTCM Java-R software. Java GUI supported MTCM was implemented in both R and MATLAB, and runs on both Microsoft Windows and Linux platforms (http://mloss.org/software/view/437/). MTCM takes input the .mat data files that record the pixel time-course of DCE-MRI data in matrices. Each row corresponds to a time frame and each column corresponds to a pixel. Results of MTCM are provided to the users via a Java-based GUI (Supplementary Fig. 5 ). 34 . It has been reported, despite validated genetic homogeneity, the different cancer 'clones' observed in a tumor, displayed notable differences in behavior during the experiments 34 . More interestingly, some of these unusual clones remained inactive initially but reemerged at later stage; therapeutic drugs preferentially eliminated persistent clones while increased the proportion of clones that were initially dormant 34 . A more likely explanation about this clonal repopulation is the involvement of one or more distinct semistable epigenetic states, on which MTCM can help to reveal quantitatively at phenotypic and functional level. To our best knowledge, MTCM is the first tool of its type to address the suggestion that "Improved mathematical models built on actual clinical and experimental observations, will likely allow us to construct these pictures in the not-so-distant future 34 ." For example, the results of MTCM may provide mechanistic models of tumor progression and responses to refine and optimize biopsy sampling, in terms of timing, number, and location of biopsies. Furthermore, some of form of intratumor heterogeneity (ITH) index may be subsequently defined as a predictor of tumor history and behaviour 38 .
In complex tissues, functional heterogeneity is of great interest since it represents the integration of various upstream factors. Since cell-cell signalling plays a critical role in tumor development and evolution, cellular heterogeneity may constitutes only a partial picture, and dissection based on cell types may provide limited information since functional aspect is largely missing 39 . MTCM (a completely unsupervised method empowered by MDL based model selection) and DCE-MRI provide a powerful and in vivo method to reveal and quantify functional heterogeneity. In contrast, many conventional analytic methods (relying on prior knowledge) may miss the low-frequency yet critical subclone(s).
Detecting the number of tissue compartment (model selection).
To discover and characterize intratumor vascular heterogeneity, the true number of the underlying tissue compartments is an unknown 'structural' model parameter and must be estimated from the data 33, 34 . To assure that MTCM provides a completely unsupervised machine learning method, we exploit the information theoretical criterion called minimum description length (MDL) 32, 35 , to detect the most appropriate number of tissue compartments in our analysis. From the MDL principle, we derived the specific MDL for MTCM model as Eq. (9) 
Data quality control (QC).
Quality control should be applied to reduce error in all image parameters. The impact of motion should be assessed and tumours for which parameter estimates are unreliable should be rejected. The level of bulk motion can be assessed for each tumor by first extracting an averaged time series plot for each tumor region of interest (ROI) on each slice in the imaging volume and then by visual assessment of the dynamic time series images. In-and throughplane motion can be investigated and a categorical score can be assigned for each tumor based on the evaluations of bulk motion. Tumors with a motion assessment score higher than a prespecified threshold should be excluded 38 .
Appendix 2. Supplementary Method
Parallelism between multi-compartment modeling and the theory of convex sets.
We now discuss the identifiability of the compartment model (2) 
By the unique convex expression of trans ( *)
which, together with the fact ( ) trans trans * 0 and ( *)
Clustering of Pixel Time Series
The purpose of multivariate clustering of normalized pixel time series is three-fold: 1) data clustering has proven to be an effective tool for reducing the impact of noise/outlier data points on model learning [44] [45] [46] ; 2) aggregation of pixel time series into a few clusters improves the efficiency of subsequent convex analysis of mixtures 36, 37 ; 3) the resultant clustered compartment model permits an automated determination of the number of underlying tissue compartments using the minimum description length (MDL) criterion 33, 38, 39 .
There has been considerable success in using SFNMs to model clustered data sets such as DCE-MRI data, taking a sum of the following general form 40-42 : ( 
where the first term corresponds to the clusters of pure volume pixels ( )
, the second term corresponds to the clusters of partial volume pixels ( ) (9) is not required in most realworld applications 40, 41 . By incorporating (7) into (9) the first term of (S12) represents the corner clusters and the second term of (S12) represents the interior clusters (as shown in Fig. 1 ). From Theorem 1 and SFNM model (S12), the clustered pixel time series set measured  is (approximately) confined within a convex set whose corner centers are the J compartment TCs 1 ,..., J C C .
It has been shown that significant computational savings can be achieved by using the EM algorithm to allow a mixture of the form (S12) to be fitted to the data 40, 41 . Determination of the parameters of the model (S12) can be viewed as a "missing data" problem in which the missing information corresponds to pixel labels . If, however, we were given a set of already clustered data with specified pixel labels, then the log likelihood (known as the "complete" data log- . Taking the expectation of (S14), we then obtain the complete data log likelihood in the form Maximization of (S15) can be performed using the two-stage form of the EM algorithm, where the pixel labels im l are treated as missing data as aforementioned. At each complete cycle of the algorithm we commence with an "old" set of parameter values Θ . We first use these parameters in the E-step to evaluate the posterior probabilities im z using Bayes theorem 
Convex Analysis of Mixtures
At this point in our analysis procedure, each pixel time-course is represented by a group of cluster centers, where both the dimensionality and noise/outlier effect are significantly reduced.
Given the obtained M cluster centers 
The optimization problems of (22) and (23) can be solved by advanced convex optimization procedure described in 43 and an exhaustive combinatorial search (for realistic values of J and M, in practice), respectively.
Model selection procedure.
One important issue concerning MTCM method is the detection of the structural parameter J in the model (the number of underlying tissue compartments or types), often called model selection 32, 44, 45 . This is indeed particularly critical in real-world applications where the true structure of the compartment models may be unknown a priori. We propose to use a widelyadopted and consistent information theoretic criterion, namely the minimum description length (MDL) 32, 39, 44 , to guide model selection. The major thrust of this approach is the formulation of a model fitting procedure in which an optimal model is selected from several competing candidates, such that the selected model best fits the observed data. MDL formulates the problem explicitly as an information coding problem in which the best model fit is measured such that it assigns high probabilities to the observed data while at the same time the model itself is not too complex to describe.
However, when the number of pixels is large as in DCE-MRI application, direct use of MDL may underestimate the value of J, due to the lack of "structure" in classical compartment models (over-parameterization) 33, 38, 39 . We therefore propose to naturally adopt and extend the clustered compartment models into the MDL formulation 52 . The proposed clustered compartment model allows all pixels belonging to the same cluster to share a common trans m K , thus greatly reducing model complexity for a given value of J (the number of convex hull corners). Specifically, a model is selected with J tissue compartments by minimizing the total description length defined by 33, 44 ( ) 
where n is the modeling residual noise assumed to follow zero-mean white Gaussian 
Estimation of pharmacokinetics parameters in MTCM.
Having determined the probabilistic pixel memberships associated with pure-volume To specify which "exterior" cluster is associated with which compartment, we investigate the temporal enhancement patterns of the "exterior" cluster centers. As aforementioned, p C is associated with the cluster of the fastest enhancement (reaching its peak most rapidly); j C is associated with the cluster of jth tissue type. We then compute p C and
We then recall the relationship 
that is the sampled system impulse response. 
that reflects the spatial heterogeneity of vascular permeability 53 . Supplementary Figure 5 -MTCM software package in R and Java is developed to implement MTCM algorithm, as well as the other algorithms widely used in blind source separation. The user-friendly Java GUI (a) can generate the tissue-specific local volume transfer constants and pharmacokinetic parameters on the right. Two pop-up windows (b) will show the projection of clustered pixels on the simplex, and (c) will display the estimated tissue-specific compartmental time-activity curves.
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